Introduction {#S1}
============

It is well established that lipids can influence the function of voltage-gated ion channels and their organization in the membrane ([@B15]; [@B18]). Specific members within the K~V~7 family of voltage-gated potassium channels have been under intense study, owing to their physiological regulation by the phospholipid PIP~2~ (phosphatidylinositol 4,5-bisphosphate; reviewed in [@B63]; [@B54]). However, several years of studies have revealed that unesterified, so called free fatty acids, may also regulate K~V~7 channel function. Polyunsaturated fatty acids (PUFAs) in particular have emerged as interesting K~V~7 modulators. This Mini Review will provide a brief essential background on K~V~7 channels and PUFAs, followed by a summary of our present understanding of PUFAs as K~V~7 channel modulators and potential future developments.

Physiological Role and General Architecture of K~V~7 Channels {#S2}
=============================================================

The K~V~7 family of voltage-gated potassium channels, of which there are five different isoforms, termed K~V~7.1 to K~V~7.5, are encoded by the *KCNQ* genes. The tissue distribution of K~V~7 subtypes varies, and the channels serve different physiological roles ([Figure 1A](#F1){ref-type="fig"}). K~V~7.1 (in complex with the auxiliary KCNE1 protein, see further details below) is most famous for generating the slow current I~Ks~ in cardiomyocytes, important for cardiac repolarization ([@B2]; [@B45]), while also maintaining the ionic balance of endolymph in the inner ear ([@B43]). Heteromers of K~V~7.2 and K~V~7.3 generate the neuronal M-current (I~M~) important for stabilizing the negative resting membrane potential of neurons and thereby regulating excitability ([@B59]; [@B13]). K~V~7.4 also contributes to maintaining the ionic balance of endolymph ([@B30]; [@B29]), as well as contributing to the negative membrane potential in smooth muscle cells at rest ([@B28]; [@B10]; [@B27]). K~V~7.5 is suggested to form heteromers with other neuronal and smooth muscle K~V~7 subtypes and contribute to their function in these tissues ([@B34]; [@B10]). Because of their important role in physiology, dysfunctional K~V~7 channels are often linked to disorders characterized by abnormal potassium ion conductance, including cardiac arrhythmia, hearing impairment, epilepsy, pain, and hypertension ([@B3]). For a more extensive overview of expression and physiological and pathological implications of K~V~7 channels, we recommend recent reviews on this topic ([@B3]; [@B40]).

![Overview of K~V~7 channel and PUFA molecular structures, and typified PUFA effects. **(A)** Schematic overview of K~V~7 subtype expression and functional role. Note that these are examples, as some K~V~7 subtypes have widespread expression and function. **(B)** Top view of K~V~7.1 (PDB: 5VMS) with central pore domain in gray and peripheral voltage-sensing domains in black. Putative localization of KCNE at one K~V~7.1 channel subunit is indicated \[each subunit may accommodate one KCNE subunit ([@B51])\]. Experimentally identified positively charged residues important for PUFA effects in K~V~7.1 ([@B38]) are highlighted in red. Sequence alignment of the S6 site (important for *G*~max~ effect) and S4 site (important for *V*~50~ effect) of all K~V~7 isoforms are provided along with a side view of relevant channel domain. **(C)** Structure of the PUFA DHA, which has a carboxyl head linked to a 22-carbon long aliphatic tail with six *cis* double bonds. Deprotonation of the carboxyl head occurs at pH exceeding the pKa of the head-group, this endows DHA with a single negative charge. **(D)** Schematic overview of PUFA effect on current amplitude (*I*~Amp~), mid-point of the *G*(*V*) curve (*V*~50~), and maximum conductance (*G*~max~) on indicated K~V~7 subtypes. Please refer to [Table 1](#T1){ref-type="table"} for further details. nd denotes not determined.](fphys-11-00641-g001){#F1}

Each *KCNQ* gene encodes one K~V~7 subunit, composed of six transmembrane segments (helices, referred to as S1--S6) and intracellular *N* and *C* termini ([@B26]). Four such K~V~7 subunits assemble into functional tetrameric K~V~7 channels, which can be either homomeric or heteromeric ([@B47]; [@B46]). A cryogenic electron microscopy structure of K~V~7.1 visualizes how transmembrane segments S5--S6 of all four subunits form the central pore domain, whereas S1 to S4 of each subunit form the peripheral voltage-sensing domains ([Figure 1B](#F1){ref-type="fig"}; [@B50]). The determined structure reveals a domain swapped architecture, meaning that the voltage-sensing domain of one subunit lies adjacent to the pore-forming segments of its neighboring subunit ([@B50]). Conserved, positively charged arginines in S4 of the voltage-sensing domain act as the primary voltage-sensing residues in K~V~7 channels ([@B44]; [@B41]). Under hyperpolarized conditions, S4 is in a "downwards," internal, conformation, and the gate (located in the internal part of S6) of the central ion conducting pore is closed ([@B14]). Upon depolarization, S4 moves via intermediate conformations to an "upwards," external, conformation ([@B4]; [@B64]; [@B53]), which triggers opening of the S6 gate and potassium conductance through the pore ([@B14]; [@B25]). Endogenous or exogenous ligands and auxiliary proteins may interact with and modulate the activity of K~V~7 channels by altering S4 movement, gate opening, or the coupling between the two. For instance, auxiliary KCNE subunits (KCNE1-5) interact with K~V~7 channels to modulate their expression and biophysical properties ([@B1]; [@B3]). Several studies assign the single-transmembrane segment of KCNE subunits to a space between neighboring voltage-sensing domains (see [Figure 1B](#F1){ref-type="fig"} for putative KCNE localization; e.g., [@B11]; [@B60]; [@B51]).

Structure and Properties of PUFAs {#S3}
=================================

Polyunsaturated fatty acids are naturally occurring lipids known to modulate the activity of numerous voltage-gated ion channels (reviewed in [@B18]). PUFA characteristics include a carboxylic acid "head-group" and an unbranched, aliphatic hydrocarbon "tail" with at least two double bonds in *cis* geometry ([Figure 1C](#F1){ref-type="fig"}). The carboxyl head-group is either uncharged or negatively charged, depending on the protonation status ([Figure 1C](#F1){ref-type="fig"}). The pKa value of carboxyl heads of PUFAs in proximity of ion channels approaches 7.4 ([@B21]; [@B37]), and so approximately 50% of PUFA head-groups are expected to be deprotonated and negatively charged at physiological pH. The *cis* double bonds allow polyunsaturated tails to bend and explore geometries that are not possible in the absence of *cis* double bonds ([@B19]; [@B61]). PUFAs are typically described according to the number of carbons and double bonds in the tail or their omega classification. [Figure 1C](#F1){ref-type="fig"} shows the structure of docosahexaenoic acid (DHA), which has 22 carbons and 6 double bonds in its tail (22:6) and is an omega-3 PUFA (i.e., the first double bond is at the 3rd carbon from the methyl end). Examples of other physiologically relevant PUFAs that can be obtained via diet or synthesized from other essential fatty acids in the human body are arachidonic acid (AA, 20:4, omega-6), linoleic acid (LA, 18:2, omega-6), alpha-linolenic acid (ALA, 18:3, omega-3), and eicosapentaenoic acid (EPA, 20:5, omega-3). Reported physiological levels of PUFAs in plasma, serum, or cerebrospinal fluid are around 10--50 μM, but may reach higher levels during, for instance, excessive dietary PUFA intake ([@B12]; [@B20]; [@B9]).

Reported PUFA Effects on K~V~7 Channels and Currents {#S4}
====================================================

[Table 1](#T1){ref-type="table"} summarizes reported PUFA effects on heterologously expressed K~V~7 channels and isolated native currents generated by K~V~7 channels. Notably, PUFA effects have thus far only been studied on K~V~7.1--K~V~7.3. A majority of studies have explored the acute effects of extracellular application of AA, ALA, DHA, EPA, or LA. These effects are achieved within the range of minutes after PUFA application. The most consistently observed PUFA effect on heterologously expressed K~V~7 channels is an increased current amplitude at a range of negative voltages, an effect reported for several PUFAs tested on K~V~7.1 and heteromeric K~V~7.2/7.3 channels ([Table 1](#T1){ref-type="table"}). Several studies report a PUFA-induced shift in the conductance *versus* voltage \[*G*(*V*)\] curve toward more negative voltages (described as negative shift in *V*~50~ in [Table 1](#T1){ref-type="table"}; [@B37]; [@B42]; [@B35]). Additionally, PUFAs may increase the maximum conductance observed at the most positive voltages (described as increase in *G*~max~ in [Table 1](#T1){ref-type="table"}; [@B7]). Both the shift in *V*~50~ and increase in *G*~max~ may contribute to the overall increase in current amplitude at different voltages. For clarity, we will refer to the three effects as "increase in current amplitude," "shift in *V*~50~," and "increase in *G*~max~." [Figure 1D](#F1){ref-type="fig"} schematically illustrates PUFA effects on each of these parameters on different K~V~7 subtypes, whereas [Table 1](#T1){ref-type="table"} reflects the complexity of effects and highlights examples of reported effects at specific PUFA concentrations. Typically, PUFA concentrations of 7 μM or higher are required to induce significant effects. Note that PUFA effects on current amplitude have typically been quantified at relatively depolarized voltages, which may not be physiologically relevant. However, because PUFAs generally also shift *V*~50~ toward negative voltages, the relative increase in current amplitude is larger at less depolarized voltages. Although studies rarely quantify PUFA effects in a more physiologically relevant voltage range, a prominent increase in current amplitude at less depolarized voltages is observed in several studies ([@B17]; [@B37]; [@B42]; [@B35]).

###### 

Summary of reported PUFA effects on indicated K~V~7 channels/currents.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Channel/current                Experimental system                     PUFA            Time perspective   Main effect(s) reported^†^                                           References
  ------------------------------ --------------------------------------- --------------- ------------------ -------------------------------------------------------------------- ------------------------
  **Heterologous expression:**                                                                                                                                                   

  hK~V~7.1                       *Xenopus* oocytes                       DHA, EPA        Acute              Faster activation kinetics\                                          [@B17]
                                                                                                            ∼*5% at* + *100 mV by 20* μ*M EPA*                                   

  hK~V~7.1                       *Xenopus* oocytes                       DHA, EPA        Acute              Increased current amplitude\                                         [@B37]
                                                                                                            Negative shift in *V*~50~\                                           
                                                                                                            *-9 to -14 mV by 70* μ*M DHA or EPA*                                 

  hK~V~7.1                       COS7                                    EPA             Acute              (No effect by 20 μM EPA)                                             [@B42]

  hK~V~7.1/KCNE1                 *Xenopus* oocytes                       DHA, EPA        Acute              Increased current amplitude\                                         [@B17]
                                                                                                            *29% at* + *40 mV by 20* μ*M DHA*\                                   
                                                                                                            Slowed activation kinetics\                                          
                                                                                                            ∼*73% at* + *100 mV by 20* μ*M EPA*                                  

  hK~V~7.1/KCNE1                 COS7                                    DHA, EPA        Acute              Increased current amplitude\                                         [@B42]
                                                                                                            *83% at* + *60 mV by 20* μ*M DHA*\                                   
                                                                                                            *37% at* + *60 mV by 20* μ*M EPA*\                                   
                                                                                                            Negative shift in *V*~50~\                                           
                                                                                                            *-9 mV by 20* μ*M EPA*                                               

  hK~V~7.1/KCNE1                 COS7                                    DHA, EPA        Prolonged          Negative or positive shift in *V*~50~\                               [@B42]
                                                                                                            *-8 mV by 20* μ*M DHA*\                                              
                                                                                                            + *10 mV by 20* μ*M EPA*                                             

  hK~V~7.1/KCNE1                 *Xenopus* oocytes                       DHA             Acute              (No effect by 70 μM DHA)                                             [@B37]

  hK~V~7.1/KCNE1                 *Xenopus* oocytes                       LA, DHA         Acute              Increased current amplitude and *G*~max~\                            [@B7]
                                                                                                            ∼*70% in G~max~ by 20* μ*M DHA*                                      

  hK~V~7.2/7.3                   *Xenopus* oocytes                       ALA, DHA, EPA   Acute              Increased current amplitude\                                         [@B35]
                                                                                                            Negative shift in *V*~50~\                                           
                                                                                                            *-7 to -11 mV by 70* μ*M ALA, DHA, or EPA*                           

  hK~V~7.2/7.3/KCNE1             *Xenopus* oocytes                       DHA             Acute              Increased current amplitude\                                         [@B35]
                                                                                                            Negative shift in *V*~50~\                                           
                                                                                                            *-8 mV by 70* μ*M DHA*                                               

  hK~V~7.2/7.3/KCNE2             *Xenopus* oocytes                       DHA             Acute              Increased current amplitude\                                         [@B35]
                                                                                                            Negative shift in *V*~50~\                                           
                                                                                                            *-5 mV by 70* μ*M DHA*                                               

  **Native current:**                                                                                                                                                            

  I~Ks~                          Guinea pig ventricular cardiomyocytes   DHA             Acute              Increased current amplitude\                                         [@B42]
                                                                                                            *38% at* + *20 mV by 10* μ*M DHA*\                                   
                                                                                                            Accelerated deactivation\                                            
                                                                                                            *19% at -40 mV by 10* μ*M DHA*                                       

  I~M~                           Rodent neuroblastoma cells              AA, DHA         Acute              Biphasic effects (both decreased and increased current amplitude)\   [@B5]
                                                                                                            *observed for 5--50* μ*M PUFA*                                       

  I~M~                           Bullfrog sympathetic neurons            AA              Acute              Increased current amplitude\                                         [@B57], [@B58]; [@B62]
                                                                                                            ∼*30--60% by 5--100* μ*M AA*                                         
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

†

Effects may vary between tested PUFAs (in such cases, most prominent effects have been listed and quantitative examples are provided in italic). AA denotes arachidonic acid, ALA denotes linolenic acid, LA denotes linoleic acid, DHA denotes docosahexaenoic acid, EPA denotes eicosapentaenoic acid. Acute effects indicate effects observed within minutes. Prolonged effects indicate effects observed within hours to days.
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In addition, PUFA effects on opening and closing kinetics have been described ([@B17]; [@B42]). However, effects on kinetics appear complex, with a range of described effects varying from PUFA to PUFA ([@B17]; [@B42]). Moreover, prolonged PUFA exposure over several days triggers a plethora of convoluted effects resulting in either negative *or* positive shift in *V*~50~, depending on PUFA ([@B42]).

Reported PUFA effects on native K~V~7 currents largely agree with effects on heterologously expressed K~V~7 channels ([Table 1](#T1){ref-type="table"}). In a majority of guinea pig ventricular cardiomyocytes, acute application of DHA increases I~Ks~ amplitude (presumably generated by K~V~7.1/KCNE1 channels; [@B42]). However, in a subset of cardiomyocytes DHA instead decreases I~Ks~ amplitude ([@B42]). Several studies observe increases in I~M~ amplitude induced by AA or DHA in bullfrog sympathetic neurons (which presumably is generated by K~V~7.2/7.3 channels; [@B57], [@B58]; [@B62]).

Impact of KCNE Subunits on PUFA Effects {#S5}
=======================================

Because KCNE subunits associate with K~V~7 channels in multiple tissues, evaluating the impact of KCNE co-expression on PUFA effects is of interest. Auxiliary subunits have been shown to affect the response of other K~V~ channels to PUFAs. For instance, DHA, or AA augmentation of the Slo1 channel is potentiated or enabled, respectively, when the channel is co-expressed with specific β subunits ([@B52]; [@B23]). Furthermore, AA modulation of K~V~4 channel inactivation kinetics is only observed if K~V~4.2 or K~V~4.3 are co-expressed with their KChIP subunit ([@B22]). We found that neither KCNE1 nor KCNE2 co-expression with K~V~7.2/7.3 affected the ability of DHA to shift *V*~50~ of K~V~7.2/7.3 ([@B35]). However, the occurrence and physiological relevance of complexes formed by K~V~7.2/7.3 and KCNE subunits remains questionable at present. Conflicting results are found regarding the impact of KCNE1 co-expression with K~V~7.1 on PUFA effects ([Table 1](#T1){ref-type="table"} and [Figure 1D](#F1){ref-type="fig"}). [@B17] report that KCNE1 is required for DHA-mediated effects on K~V~7.1 current amplitude, as they find that 20 μM of DHA increases the current amplitude of K~V~7.1/KCNE1, but not K~V~7.1. By comparison, 20 μM of EPA slowed activation kinetics for K~V~7.1/KCNE1 without affecting current amplitude ([@B17]). In contrast, we report that DHA at concentrations of 7 μM or higher shifts *V*~50~ of K~V~7.1 toward negative voltages and that the presence of KCNE1 largely abolishes this *V*~50~ effect ([@B37]; [@B7]). However, we observe a DHA-induced increase in K~V~7.1/KCNE1 current amplitude and *G*~max~ ([@B7]). A third study, by Moreno and colleagues, reports that 20 μM of DHA or EPA increases K~V~7.1/KCNE1 current amplitude and shifts *V*~50~ of K~V~7.1/KCNE1 toward negative voltages ([@B42]). However, no EPA effect is observed on K~V~7.1 alone ([@B42]). The reason for these conflicting findings is not clear. One contributing factor may be the use of different expression systems (*Xenopus* oocytes *versus* mammalian COS7 cells). As previously remarked ([@B56]), higher PUFA concentrations may be required in experiments with *Xenopus* oocytes than for mammalian cells to induce comparable effects. Another aspect to consider may be the method of PUFA application. We note larger DHA effects on current amplitude upon constant DHA perfusion compared to a single DHA application ([@B37]; [@B7]). Both Doolan *et al.*, and Moreno *et al.*, describe results employing PUFA perfusion.

PUFA Properties Important for K~V~7 Effects {#S6}
===========================================

Previous studies have shown that PUFAs may interact directly with diverse ion channels to modulate their activity ([@B18]). [@B42] concluded that the concurrent increase in K~V~7.1/KCNE1 current amplitude and negative shift in *V*~50~ implicate an effect on channel gating as the primary mechanism. We made the same observation in our initial work ([@B37]). In subsequent work we have since explored this possibility utilizing PUFA analogs, site-directed mutagenesis, and pH manipulation.

We find that a negatively charged PUFA head-group is critical to the shift in *V*~50~ of K~V~7.1 and K~V~7.2/7.3 toward negative voltages. Fully deprotonated PUFAs (promoted by an alkaline extracellular solution) cause larger negative *V*~50~ shifts ([@B37]; [@B32]; [@B6]). Protonated PUFAs and uncharged PUFA analogs (PUFA methyl esters) are unable to shift *V*~50~ ([@B37], [@B35]). Positively charged PUFA analogs (PUFA amines) instead shift *V*~50~ toward more positive voltages ([@B37], [@B35]; [@B32]). This set of experiments implies an electrostatic mechanism of action underlying PUFA effects on *V*~50~, and shows that the magnitude of this electrostatic effect is determined by the protonation status of the PUFA head-group. Notably, we observe clear activating effects by PUFAs on K~V~7.1/KCNE1 (comparable to those on K~V~7.1 alone) during experimental conditions that promote PUFA deprotonation ([@B37]; [@B32]). This suggests that the lack of PUFA effects on K~V~7.1/KCNE1 in our hands is because of KCNE1-induced protonation of the PUFA head-group. Moreover, these findings suggest that provided the head-group of a given PUFA analog has a low pKa value (and thus is deprotonated at physiological pH) said PUFA analog can be utilized to achieve greater effects on K~V~7.1 alone at physiological pH while simultaneously retaining activating effects on K~V~7.1/KCNE1 at physiological pH.

The PUFA head-group is not the sole determinant of the magnitude of PUFA effects. The first indication of this came from studies by [@B17] and [@B42] both of which show DHA induces overall greater effects on K~V~7.1/KCNE1 than EPA does. This is in agreement with our comparison of 16 PUFAs with different tail properties, in which we find that PUFAs with double bonds proximal to the head-group have a higher apparent affinity to K~V~7.1/KCNE1, compared with PUFAs with more distal double bonds ([@B6]). In contrast, there was either no or weak correlation between tail length or number of double tail bonds and K~V~7.1/KCNE1 effects ([@B6]). The proximal localization of double bonds relative to the head-group of DHA may contribute to the relatively greater effect, when compared to EPA at specific concentrations. The mechanistic basis for why proximal double bonds enhance PUFA interaction with K~V~7.1 remains unknown, but may be related to flexibility in the hydrocarbon tail. Studies of PUFA interaction with the Slo1-β1 BK channel suggest that bending at specific carbons distally in the hydrocarbon tail are required for interaction with the channel ([@B55]). Speculatively, greater bending capabilities close to the head-group may be required for high affinity binding of PUFAs to K~V~7.1.

Proposed Direct PUFA Sites of Action in K~V~7 {#S7}
=============================================

Polyunsaturated fatty acid analogs with lower head-group pKa values have been instrumental in determining the mechanism of action of PUFAs on K~V~7.1. PUFA analogs with glycine or taurine head-groups have estimated pKa values that are 1 and 5.5 units lower than that of carboxyl head-groups, respectively, ([@B7]), and are examples of PUFA analogs with exaggerated acute effects on *V*~50~ of both K~V~7.1 and K~V~7.1/KCNE1 at physiological pH ([@B37]). In experiments utilizing DHA-glycine (DHA-Gly) or AA-taurine (N-AT), we have shown that PUFA analogs interact with S4 to shift *V*~50~. This is observed in voltage-clamp fluorometry experiments that track S4 movement as a PUFA-induced shift in S4 movement toward negative voltages ([@B37], [@B36]). Individual mutations of the two top arginines in S4 of K~V~7.1 into uncharged glutamines (R228Q and R231Q) either reduce or abrogate entirely the ability of PUFAs to shift *V*~50~ of K~V~7.1 and K~V~7.1/KCNE1 ([@B37], [@B38]). These findings suggest that electrostatic interaction between the negative PUFA head-group and these positively charged arginines in S4 facilitates the upward S4 movement, which contributes to the PUFA effect on *V*~50~ (illustrated as "S4 site" in [Figure 1B](#F1){ref-type="fig"}).

Although charge-neutralizing mutation of S4 arginines removes the *V*~50~ effect of PUFAs, an increase in *G*~max~ of K~V~7.1 and K~V~7.1/KCNE1 is still observed ([@B38]). This increase in *G*~max~ is also electrostatic in nature, as it is abolished following mutation of a lysine at the top of S6 into an uncharged glutamine ([@B38]). Experiments combined with molecular dynamics simulations suggest that electrostatic interaction between the negative PUFA head-group and the positively charged lysine at position 326 of S6 (illustrated as "S6 site" in [Figure 1B](#F1){ref-type="fig"}) triggers conformational changes in the ion-conducting pore in and near the selectivity filter. These conformational changes appear to promote potassium ion conductance in a way that contributes to the PUFA effect on *G*~max~. Altogether, these findings suggest that PUFAs have at least two independent sites of electrostatic action in K~V~7.1 channels. Similar sites have been suggested for K~V~7.2 and, to some extent, K~V~7.3 ([@B31]).

Proposed Indirect PUFA Effects on K~V~7 {#S8}
=======================================

Besides direct effects, PUFAs may influence K~V~7 channels through other mechanisms, including altering bilayer organization and properties or generating active PUFA metabolites. Indication of additional pathways of PUFA modulation of K~V~7 channels comes from prolonged exposure (48 h) of K~V~7.1/KCNE1 channels to DHA or EPA ([@B42]). For instance, prolonged DHA or EPA exposure reduces total K~V~7.1 protein levels in COS7 cells, presumably by inducing protein degradation ([@B42]). Prolonged exposure also triggers spatial redistribution of K~V~7.1/KCNE1 in the membrane, presumably by disruption of lipid rafts ([@B42]). It has been speculated that mechanical properties of the membrane (such as thickness and stiffness) may contribute to altered K~V~7.1/KCNE1 behavior in different membrane microdomains ([@B42]). Given that PUFAs regulate other ion channels through modulating the mechanical properties of membranes ([@B8]), the possible contributions of such indirect PUFA effects on K~V~7 channels in different microdomains warrants further studies.

Regarding the influence of active metabolites, AA is central in oxygenase-driven metabolic pathways that generate leukotrienes and prostaglandins ([@B48]). Treatment of bullfrog sympathetic neurons with an inhibitor of the lipoxygenase pathway reduces I~M~ and prevents AA-mediated increases in I~M~ amplitude ([@B57]; [@B62]), presumably by impeding downstream AA metabolites that modulate I~M~ effects ([@B62]). These findings highlight the multifaceted nature of PUFA signaling and the challenges of dissecting underlying mechanisms in more complex cellular systems and longer time scales.

Future Directions {#S9}
=================

Several studies report that micromolar concentrations of PUFAs increase K~V~7.1-7.3 currents and have provided insights into mechanisms of how acute and prolonged PUFA exposure impacts K~V~7 channels. However, there are still several open questions. For instance:

1.  Given the conservation among K~V~7 channels of charged residues identified to be crucial to PUFA effects ([Figure 1B](#F1){ref-type="fig"}), are the effects and underlying mechanisms of action conserved among all K~V~7 isoforms?

2.  What is the physiological relevance of PUFA effects reported on heterologously expressed K~V~7 channels? PUFA have been reported to alter cardiac and neuronal excitability \[e.g., by shortening action potential duration and QT interval, and increasing the threshold for action potential firing (e.g., [@B33]; [@B8]; [@B16]; [@B35]; [@B49])\], and vascular tone \[by promoting vascular smooth muscle relaxation (e.g., [@B24]; [@B39])\]. However, as PUFAs act on many types of channels, the extent of Kv7 contribution to such general effects remain to be determined.

3.  Can a mechanistic understanding of PUFA modulation of K~V~7 channels open up new therapeutic avenues? For instance, how viable is modulation of circulating PUFA levels for the tuning of neuronal and cardiac excitability, and what are the prospects of PUFA analogs as pharmacological K~V~7 channel activators?

To conclude, PUFAs modulate the activity of K~V~7 channels through a range of mechanisms. Studies of heterologously expressed K~V~7 channels have revealed important insights into mechanisms underlying K~V~7 channel activation via direct PUFA-channel interactions. However, several aspects of PUFA modulation of K~V~7 channels remain unclear and require further studies. This is particularly true for comprehending the compounded results of both direct and indirect PUFA effects in differing time scales and cellular systems.
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